News

Verve Therapeutics (VERV) was downgraded to a Hold Rating at William Blair
Detailed price information for Verve Therapeutics Inc (VERV-Q) from The Globe and Mail including charting and trades.
KAAL TV30m
Global shares gain and oil prices slip as markets eye the Mideast conflict, await Fed’s decision
Global shares are mostly higher and oil prices have slipped as investors await a decision on interest rates by the Federal ...
US stock market today: Wall Street stays flat ahead of Fed policy call, oil dips on easing fears; global markets trade mixed
Wall Street remained steady as investors awaited the Federal Reserve's policy decision, while global markets reacted to ...
Verve Therapeutics downgraded to Hold from Buy at Canaccord
Canaccord downgraded Verve Therapeutics (VERV) to Hold from Buy with a price target of $13, down from $39, after Eli Lilly (LLY) announced a definitive agreement to acquire Verve. Lilly will commence ...
AB InBev announces $17M investment in Houston brewery
Anheuser-Busch (BUD) announced a new $17M investment in its Houston, TX brewery. This $17M investment in its Houston brewery ...
Bariatric surgery better than GLP-1 drugs for weight loss : ASMBS study
A study presented at the American Society for Metabolic and Bariatric Surgery highlighted that bariatric surgeries, ...